Standout Papers
Citation Impact
Citing Papers
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death
2000
Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
2021 StandoutNobel
Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: Systematic review and meta‐analysis
2010
Asialoglycoprotein receptor mediated hepatocyte targeting — Strategies and applications
2015
Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients
1998
Inflammation and cancer
2002 StandoutNature
Pathogenesis of hepatitis B virus infection
2010
Immunosuppressive networks in the tumour environment and their therapeutic relevance
2005 Standout
Hepatocellular carcinoma
2018 Standout
A Model to Predict Survival in Patients With End–Stage Liver Disease
2001 Standout
Hepatitis C Virus Infection
2001 Standout
Global Cancer Statistics, 2002
2005 Standout
Rising Incidence of Hepatocellular Carcinoma in the United States
1999 Standout
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
1998 Standout
Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection
1998
Increase in the Concentration of Carbon 18 Monounsaturated Fatty Acids in the Liver with Hepatitis C: Analysis in Transgenic Mice and Humans
2001
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
Natural history of hepatitis C
1997
Hepatocellular carcinoma
2012 Standout
Long interval between HCV infection and development of hepatocellular carcinoma
1995
Sustained virological response to interferon-α is associated with improved outcome in HCV-related cirrhosis: A retrospective study
2007
Expression and Immune Response to Hepatitis C Virus Core Dna-Based Vaccine Constructs
1996
Hepatitis-C-virus-like internal ribosome entry sites displace eIF3 to gain access to the 40S subunit
2013 StandoutNatureNobel
A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma
1998
Management of Hepatocellular Carcinoma: An Update Δσ
2011 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Global cancer statistics
2011 Standout
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis
1996
Liver-Derived Hepatitis C Virus (HCV)-Specific CD4+ T Cells Recognize Multiple HCV Epitopes and Produce Interferon Gamma
2000 StandoutNobel
Hepatitis C virus and hepatocellualr carcinoma
1994
Hepatitis C virus NS4A and NS4B proteins suppress translation in vivo
2001
Cell culture–produced hepatitis C virus does not infect peripheral blood mononuclear cells
2008 StandoutNobel
Priming of hepatitis C virus-specific cytotoxic t lymphocytes in mice following portal vein injection of a liver-specific plasmid DNA
2000 StandoutNobel
Characteristics of patients with dual infection by hepatitis B and C viruses
1998
Structural and mechanistic insights into hepatitis C viral translation initiation
2006 StandoutNobel
Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma
2005
Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease
2008
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
2012 Standout
Glycogen synthase kinase 3β inhibitors prevent hepatitis C virus release/assembly through perturbation of lipid metabolism
2017 StandoutNobel
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults
2010 StandoutNobel
The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection
2007
Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C
2005
Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide
1996 StandoutNobel
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Hepatitis C and liver transplantation
1995
Viruses and hepatocellular carcinoma.
1994
The role of diabetes in hepatocellular carcinoma: a case-control study among United States veterans
2001
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
2013 StandoutNobel
A Novel Small Molecule Inhibitor of Hepatitis C Virus Entry
2010
Infections as a major preventable cause of human cancer
2000
Infection in Solid-Organ Transplant Recipients
2007 Standout
Natural history of liver fibrosis progression in patients with chronic hepatitis C
1997 Standout
The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice
1998
Correlation of serum HCV RNA and alanine aminotransferase levels in chronic hepatitis C patients during treatment with ribavirin
1994
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
The dynamic nature of the four-way junction of the hepatitis C virus IRES
2003
Replication of hepatitis C virus
2007 StandoutNobel
NF-κB: linking inflammation and immunity to cancer development and progression
2005 Standout
Serology-Enabled Discovery of Genetically Diverse Hepaciviruses in a New Host
2012 StandoutNobel
Hepatocellular Carcinoma
2019 Standout
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Relation of Interferon Therapy and Hepatocellular Carcinoma in Patients with Chronic Hepatitis C
1998
Retrospective analysis of the effect of interferon therapy on the clinical outcome of patients with viral cirrhosis
1998
Hepatitis C Virus Internal Ribosome Entry Site (IRES) Stem Loop IIId Contains a Phylogenetically Conserved GGG Triplet Essential for Translation and IRES Folding
2000 StandoutNobel
Recombinant Hepatitis C Virus Envelope Glycoprotein Vaccine Elicits Antibodies Targeting Multiple Epitopes on the Envelope Glycoproteins Associated with Broad Cross-Neutralization
2014 StandoutNobel
Clonal B cells in patients with hepatitis C virus–associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset
2011 StandoutNobel
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
An N-Terminal Amphipathic Helix in Hepatitis C Virus (HCV) NS4B Mediates Membrane Association, Correct Localization of Replication Complex Proteins, and HCV RNA Replication
2004 StandoutNobel
The C Terminus of Hepatitis C Virus NS4A Encodes an Electrostatic Switch That Regulates NS5A Hyperphosphorylation and Viral Replication
2007 StandoutNobel
A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1
2019 StandoutNobel
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
THE EPIDEMIOLOGY OF VIRAL HEPATITIS IN THE UNITED STATES
1994
Treatment of chronic type B and C hepatitis with interferon alfa: An economic appraisal
1995
V H 1-69 gene is preferentially used by hepatitis C virus–associated B cell lymphomas and by normal B cells responding to the E2 viral antigen
2001
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG
2016 StandoutNobel
Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine
2018 StandoutNobel
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells
2013 StandoutNobel
Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides
1995
Development of hepatocellular carcinoma after clearance of hepatitis C virus with interferon therapy.
1997
Modified E2 Glycoprotein of Hepatitis C Virus Enhances Proinflammatory Cytokines and Protective Immune Response
2022 StandoutNobel
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
2004 StandoutNobel
Works of Roberto Giuseppetti being referenced
A pre-S/S CHO-derived hepatitis B virus vaccine protects woodchucks from WHV productive infection
2005
Hepatitis C Virus Infection as a Risk Factor for Hepatocellular Carcinoma in Patients with Cirrhosis
1992
Hepatotropic conjugate of adenine arabinoside monophosphate with lactosaminated poly-l-lysine
1997
Activation of the N-myc2 Oncogene by Woodchuck Hepatitis Virus Integration in the Linked Downstreamb3nLocus in Woodchuck Hepatocellular Carcinoma
1999
Antiviral activity of ganciclovir, 9-(1,3-dihydroxy-2-propoxymethyl) guanine against woodchuck hepatitis virus: quantitative measurement of woodchuck hepatitis virus DNA using storage phosphor technology.
1998